#POLB Poolbeg Pharma – POLB 001 Patent Portfolio Strengthened

Key highlights ·      Patent granted for use of certain p38 MAP kinase inhibitors for the treatment of hypercytokinaemia ·      Allows for use in combination with an antiviral agent ·      Patent enhances the robust IP portfolio protecting Poolbeg’s growing pipeline   8 March 2023 – Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’),  a leading infectious disease focused biopharmaceutical company, announces that […]

#TEK TekCapital PLC – NOVELSAT and Guident Partnership

Tekcapital Plc (AIM: TEK), (OTCQB: TEKCF), the UK intellectual property investment group focused on transforming university technologies into valuable products that can improve people’s lives, is pleased to announce that portfolio company Guident Ltd. (“Guident”) has partnered with Novelsat Ltd. (NOVELSAT), a global leader in content connectivity, to develop an innovative always-on, ubiquitous remote monitor […]

#TEK Tek Capital PLC – Guident Portfolio Company Update

Tekcapital Plc (AIM: TEK), (OTCQB: TEKCF), the UK intellectual property investment group focused on transforming university technologies into valuable products that can improve people’s lives, is pleased to announce that Guident Ltd. (“Guident”) has executed a letter of intent with Auve Tech OÜ (“Auve Tech”) to provide remote monitoring and control (“RMCC”) services for Auve […]

#TEK Tek Capital PLC – US Salt forms Strategic Partnership with MicroSalt

Tekcapital Plc (AIM: TEK), (OTCQB: TEKCF) the UK intellectual property investment group focused on creating valuable products that can improve people’s lives, is pleased to announce that MicroSalt has entered into an agreement with US Salt LLC (“US Salt”) for the distribution and delivery of MicroSalt’s low-sodium solutions. “We are proud to work with US […]

#TEK Tekcapital PLC investee co #BELL Belluscura PLC – appoints Senior VP of Global Sales

Belluscura plc (AIM: BELL), a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announces that Robert (“Bob”) Fary has joined the Company as Senior Vice President of Global Sales.   Bob has thirty-years of experience in the respiratory industry where he has held leadership roles at major oxygen concentrator manufacturers and […]

#TEK TekCapital Plc investee co. #BELL Belluscura Plc – Year-end Trading Update

LONDON, U.K. AND PLANO, TX, U.S. (13 January 2023) Belluscura plc (AIM: BELL), a leading medical device developer focused on lightweight and portable oxygen concentrator (“POC”) technology, provides a trading update for the year ended 31 December 2022. The Group is pleased to announce that it has made considerable progress this year. Since the launch of […]

#TM1 Technology Minerals Plc – Recyclus appoints Head of Research and Development

Technology Minerals Plc (LSE: TM1), the first listed UK company focused on creating a sustainable circular economy for battery metals, is pleased to announce that its 49% owned battery recycling business, Recyclus Group Ltd (“Recyclus”), has appointed Nick Pickard as Head of Research and Development, effective from 3 January 2023.   Nick has more than […]

#POLB Poolbeg Pharma PLC – Metabolic diseases oral delivery licence signed

Clinical trial to demonstrate technology can safely deliver GLP-1 to commence in H1 2023 Prof Brendan Buckley joins Poolbeg’s Scientific Advisory Board to guide clinical development of technology Licence expands Poolbeg’s existing exclusive licence to AnaBio’s oral vaccine delivery technology Investor Meet Company presentation on 14 December 2022 at 5:30pm Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, […]

#TEK Tek Capital PLC – Investee Company #BELL Belluscura PLC

Belluscura, a leading medical device developer focused on lightweight and portable oxygen enrichment technology, is pleased to announce it has entered into its first international distribution agreement outside of the US, with MedHealth Supplies of South Africa (“MedHealth”). Following the distribution agreement, MedHealth has placed orders for both 2022 and 2023, with deliveries to commence […]